Jennifer Cultrera, MD

Where You Are:
Jennifer Cultrera, MD

"It is imperative to discover novel agents to improve patient survival and offer new treatment options to patients with hematologic malignancies."

Office  (813) 745-4294

Education And Training
  • MS, The University of Texas Health Science Center, Houston, 2009 - Cancer Biology
  • Fellow, The University of Texas M.D. Anderson Cancer Center, Houston, 2009 - Hematology & Medical Oncology
  • Resident, University of Miami, Miller School of Medicine, 2006 - Internal Medicine
  • MD, University of Miami, Miller School of Medicine, 2003


B-cell non-Hodgkin’s lymphomas are a diverse group of disorders with significant biological and clinical heterogeneity. Albeit several subtypes respond well to traditional therapy; high grade forms of the disease often relapse. It is imperative to discover novel therapeutics to help improve patient survival to offer patients new treatment options.I have always had a particular affinity towards understanding the intricate molecular mechanisms of apoptosis in response to targeted agents, specifically histone deacetylase inhibition. My prior work involved understanding the synergy between histone deacetylase inhibition and proteasome inhibition in patients with lymphoma. In discovering the multiple pathways activated in response to treatment by these agents, we can further understand the biology of tumor genesis and one day hope to halt or even prevent this devastating disease.

 

  • Alvarnas JC, Brown PA, Aoun P, Ballen KK, Bellam N, Blum W, Boyer MW, Carraway HE, Coccia PF, Coutre SE, Cultrera J, Damon LE, Deangelo DJ, Douer D, Frangoul H, Frankfurt O, Goorha S, Millenson MM, O'Brien S, Petersdorf SH, Rao AV, Terezakis S, Uy G, Wetzler M, Zelenetz AD, Naganuma M, Gregory KM. Acute lymphoblastic leukemia. J Natl Compr Canc Netw. 2012 Jul;10(7):858-914. Pubmedid: 22773801.
  • Cultrera JL, Dalia SM. Diffuse large B-cell lymphoma: current strategies and future directions. Cancer Control. 2012 Jul;19(3):204-213. Pubmedid: 22710896.
  • Liu JJ, Zhang L, Ayala E, Field T, Ochoa-Bayona JL, Perez L, Bello CM, Chervenick PA, Bruno S, Cultrera JL, Baz RC, Kharfan-Dabaja MA, Raychaudhuri J, Sotomayor EM, Sokol L. Human immunodeficiency virus (HIV)-negative plasmablastic lymphoma: a single institutional experience and literature review. Leuk Res. 2011 Dec;35(12):1571-1577. Pubmedid: 21752466.
  • Komrokji RS, Al Ali NH, Beg MS, Safa MM, Rollison D, Kharfan-Dabaja M, Bello C, Cultrera J, Sokol L, Pinilla-Ibarz J, Sotomayor EM. Outcome of diffuse large B-Cell lymphoma in the United States has improved over time but racial disparities remain: review of SEER data. Clin Lymphoma Myeloma Leuk. 2011 Jun;11(3):257-260. Pubmedid: 21658652.
TOOLS:   Font Size small font resizer separator font resizer separator big font resizer